{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:21:32Z","timestamp":1791973292601,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00277-018-3555-7","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T12:28:01Z","timestamp":1544531281000},"page":"679-689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET\/MRI"],"prefix":"10.1007","volume":"98","author":[{"given":"Renato","family":"Zambello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crim\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albana","family":"Lico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Baril\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Branca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Guolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Varin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Vezzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Checuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanna","family":"Scapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Berno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercole","family":"De Biasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Vio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpietro","family":"Semenzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Zucchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Lacognata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"issue":"1","key":"3555_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/s-2001-12920","volume":"5","author":"FE Lecouvet","year":"2001","unstructured":"Lecouvet FE, Vande Berg BC, Malghem J, Maldague BE (2001) Magnetic resonance and computed tomography imaging in multiple myeloma. Semin Musculoskelet Radiol 5(1):43\u201355","journal-title":"Semin Musculoskelet Radiol"},{"issue":"6","key":"3555_CR2","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2214\/ajr.178.6.1781429","volume":"178","author":"AH Mahnken","year":"2002","unstructured":"Mahnken AH, Wildberger JE, Gehbauer G, Schmitz-Rode T, Blaum M, Fabry U, Gunther RW (2002) Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. AJR Am J Roentgenol 178(6):1429\u20131436. \n                    https:\/\/doi.org\/10.2214\/ajr.178.6.1781429","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"3555_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.5312\/wjo.v5.i3.272","volume":"5","author":"T Derlin","year":"2014","unstructured":"Derlin T, Bannas P (2014) Imaging of multiple myeloma: current concepts. World J Orthop 5(3):272\u2013282. \n                    https:\/\/doi.org\/10.5312\/wjo.v5.i3.272","journal-title":"World J Orthop"},{"key":"3555_CR4","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1200\/EDBK_159074","volume":"35","author":"E Terpos","year":"2016","unstructured":"Terpos E, Dimopoulos MA, Moulopoulos LA (2016) The role of imaging in the treatment of patients with multiple myeloma in 2016. Am Soc Clin Oncol Educ Book 35:e407\u2013e417. \n                    https:\/\/doi.org\/10.14694\/EDBK_159074","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"8","key":"3555_CR5","doi-asserted-by":"publisher","first-page":"e599","DOI":"10.1038\/bcj.2017.78","volume":"7","author":"J Hillengass","year":"2017","unstructured":"Hillengass J, Moulopoulos LA, Delorme S, Koutoulidis V, Mosebach J, Hielscher T, Drake M, Rajkumar SV, Oestergaard B, Abildgaard N, Hinge M, Plesner T, Suehara Y, Matsue K, Withofs N, Caers J, Waage A, Goldschmidt H, Dimopoulos MA, Lentzsch S, Durie B, Terpos E (2017) Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group. Blood Cancer J 7(8):e599. \n                    https:\/\/doi.org\/10.1038\/bcj.2017.78","journal-title":"Blood Cancer J"},{"issue":"965","key":"3555_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1259\/bjr\/21850180","volume":"81","author":"M Horger","year":"2008","unstructured":"Horger M, Pereira P, Claussen CD, Kanz L, Vonthein R, Denecke B, Driessen C (2008) Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters. Br J Radiol 81(965):386\u2013396. \n                    https:\/\/doi.org\/10.1259\/bjr\/21850180","journal-title":"Br J Radiol"},{"issue":"3","key":"3555_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/j.semnuclmed.2007.01.002","volume":"37","author":"JS Blebea","year":"2007","unstructured":"Blebea JS, Houseni M, Torigian DA, Fan C, Mavi A, Zhuge Y, Iwanaga T, Mishra S, Udupa J, Zhuang J, Gopal R, Alavi A (2007) Structural and functional imaging of normal bone marrow and evaluation of its age-related changes. Semin Nucl Med 37(3):185\u2013194. \n                    https:\/\/doi.org\/10.1053\/j.semnuclmed.2007.01.002","journal-title":"Semin Nucl Med"},{"key":"3555_CR8","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1038\/bcj.2015.57","volume":"5","author":"Y Nishida","year":"2015","unstructured":"Nishida Y, Matsue Y, Suehara Y, Fukumoto K, Fujisawa M, Takeuchi M, Ouchi E, Matsue K (2015) Clinical and prognostic significance of bone marrow abnormalities in the appendicular skeleton detected by low-dose whole-body multidetector computed tomography in patients with multiple myeloma. Blood Cancer J 5:e329. \n                    https:\/\/doi.org\/10.1038\/bcj.2015.57","journal-title":"Blood Cancer J"},{"issue":"12","key":"3555_CR9","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BG, Miguel JF (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15(12):e538\u2013e548. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"issue":"4","key":"3555_CR10","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","volume":"18","author":"M Cavo","year":"2017","unstructured":"Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, Hillengass J, Engelhardt M, Usmani SZ, Vesole DH, San-Miguel J, Kumar SK, Richardson PG, Mikhael JR, da Costa FL, Dimopoulos MA, Zingaretti C, Abildgaard N, Goldschmidt H, Orlowski RZ, Chng WJ, Einsele H, Lonial S, Barlogie B, Anderson KC, Rajkumar SV, Durie BGM, Zamagni E (2017) Role of (18)F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol 18(4):e206\u2013e217. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(17)30189-4","journal-title":"Lancet Oncol"},{"issue":"6","key":"3555_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/JCO.2014.57.9961","volume":"33","author":"MA Dimopoulos","year":"2015","unstructured":"Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE, Raje N, Sezer O, Zweegman S, Shah J, Badros A, Shimizu K, Moreau P, Chim CS, Lahuerta JJ, Hou J, Jurczyszyn A, Goldschmidt H, Sonneveld P, Palumbo A, Ludwig H, Cavo M, Barlogie B, Anderson K, Roodman GD, Rajkumar SV, Durie BG, Terpos E (2015) Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol 33(6):657\u2013664. \n                    https:\/\/doi.org\/10.1200\/JCO.2014.57.9961","journal-title":"J Clin Oncol"},{"issue":"2","key":"3555_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ, European Association of Nuclear M (2015) FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42(2):328\u2013354. \n                    https:\/\/doi.org\/10.1007\/s00259-014-2961-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"3555_CR13","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.crad.2017.05.004","volume":"72","author":"C Lacognata","year":"2017","unstructured":"Lacognata C, Crimi F, Guolo A, Varin C, De March E, Vio S, Ponzoni A, Barila G, Lico A, Branca A, De Biasi E, Gherlinzoni F, Scapin V, Bissoli E, Berno T, Zambello R (2017) Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma. Clin Radiol 72(10):850\u2013857. \n                    https:\/\/doi.org\/10.1016\/j.crad.2017.05.004","journal-title":"Clin Radiol"},{"issue":"2","key":"3555_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1148\/radiol.2016160363","volume":"282","author":"V Koutoulidis","year":"2017","unstructured":"Koutoulidis V, Fontara S, Terpos E, Zagouri F, Matsaridis D, Christoulas D, Panourgias E, Kastritis E, Dimopoulos MA, Moulopoulos LA (2017) Quantitative diffusion-weighted imaging of the bone marrow: an adjunct tool for the diagnosis of a diffuse MR imaging pattern in patients with multiple myeloma. Radiology 282(2):484\u2013493. \n                    https:\/\/doi.org\/10.1148\/radiol.2016160363","journal-title":"Radiology"},{"issue":"23","key":"3555_CR15","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1182\/blood-2011-06-361386","volume":"118","author":"E Zamagni","year":"2011","unstructured":"Zamagni E, Patriarca F, Nanni C, Zannetti B, Englaro E, Pezzi A, Tacchetti P, Buttignol S, Perrone G, Brioli A, Pantani L, Terragna C, Carobolante F, Baccarani M, Fanin R, Fanti S, Cavo M (2011) Prognostic relevance of 18-F FDG PET\/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation. Blood 118(23):5989\u20135995. \n                    https:\/\/doi.org\/10.1182\/blood-2011-06-361386","journal-title":"Blood"},{"issue":"12","key":"3555_CR16","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/j.ejrad.2013.08.036","volume":"82","author":"D Ippolito","year":"2013","unstructured":"Ippolito D, Besostri V, Bonaffini PA, Rossini F, Di Lelio A, Sironi S (2013) Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM). Eur J Radiol 82(12):2322\u20132327. \n                    https:\/\/doi.org\/10.1016\/j.ejrad.2013.08.036","journal-title":"Eur J Radiol"},{"key":"3555_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1182\/asheducation-2015.1.272","volume":"2015","author":"SV Rajkumar","year":"2015","unstructured":"Rajkumar SV (2015) Evolving diagnostic criteria for multiple myeloma. Hematology Am Soc Hematol Educ Program 2015:272\u2013278. \n                    https:\/\/doi.org\/10.1182\/asheducation-2015.1.272","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"suppl_4","key":"3555_CR18","doi-asserted-by":"publisher","first-page":"iv52","DOI":"10.1093\/annonc\/mdx096","volume":"28","author":"P Moreau","year":"2017","unstructured":"Moreau P, San Miguel J, Sonneveld P, Mateos MV, Zamagni E, Avet-Loiseau H, Hajek R, Dimopoulos MA, Ludwig H, Einsele H, Zweegman S, Facon T, Cavo M, Terpos E, Goldschmidt H, Attal M, Buske C, Committee EG (2017) Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28(suppl_4):iv52\u2013iv61. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdx096","journal-title":"Ann Oncol"},{"issue":"10","key":"3555_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41408-018-0124-1","volume":"8","author":"LA Moulopoulos","year":"2018","unstructured":"Moulopoulos LA, Koutoulidis V, Hillengass J, Zamagni E, Aquerreta JD, Roche CL, Lentzsch S, Moreau P, Cavo M, Miguel JS, Dimopoulos MA, Rajkumar SV, Durie BGM, Terpos E, Delorme S (2018) Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group. Blood Cancer J 8(10):95. \n                    https:\/\/doi.org\/10.1038\/s41408-018-0124-1","journal-title":"Blood Cancer J"},{"issue":"4","key":"3555_CR20","doi-asserted-by":"publisher","first-page":"884","DOI":"10.2214\/AJR.12.9653","volume":"200","author":"A Agarwal","year":"2013","unstructured":"Agarwal A, Chirindel A, Shah BA, Subramaniam RM (2013) Evolving role of FDG PET\/CT in multiple myeloma imaging and management. AJR Am J Roentgenol 200(4):884\u2013890. \n                    https:\/\/doi.org\/10.2214\/AJR.12.9653","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"3555_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bjh.14545","volume":"177","author":"D Ippolito","year":"2017","unstructured":"Ippolito D, Talei Franzesi C, Spiga S, Besostri V, Pezzati S, Rossini F, Sironi S (2017) Diagnostic value of whole-body ultra-low dose computed tomography in comparison with spinal magnetic resonance imaging in the assessment of disease in multiple myeloma. Br J Haematol 177(3):395\u2013403. \n                    https:\/\/doi.org\/10.1111\/bjh.14545","journal-title":"Br J Haematol"},{"issue":"3","key":"3555_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00256-008-0607-4","volume":"38","author":"TG Gleeson","year":"2009","unstructured":"Gleeson TG, Moriarty J, Shortt CP, Gleeson JP, Fitzpatrick P, Byrne B, McHugh J, O'Connell M, O'Gorman P, Eustace SJ (2009) Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI). Skelet Radiol 38(3):225\u2013236. \n                    https:\/\/doi.org\/10.1007\/s00256-008-0607-4","journal-title":"Skelet Radiol"},{"issue":"6","key":"3555_CR23","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1158\/0008-5472.CAN-03-1131","volume":"64","author":"S Yaccoby","year":"2004","unstructured":"Yaccoby S, Wezeman MJ, Henderson A, Cottler-Fox M, Yi Q, Barlogie B, Epstein J (2004) Cancer and the microenvironment: myeloma-osteoclast interactions as a model. Cancer Res 64(6):2016\u20132023","journal-title":"Cancer Res"},{"issue":"2","key":"3555_CR24","first-page":"192","volume":"91","author":"S Yaccoby","year":"2006","unstructured":"Yaccoby S, Wezeman MJ, Zangari M, Walker R, Cottler-Fox M, Gaddy D, Ling W, Saha R, Barlogie B, Tricot G, Epstein J (2006) Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model. Haematologica 91(2):192\u2013199","journal-title":"Haematologica"},{"issue":"8","key":"3555_CR25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrc2189","volume":"7","author":"T Hideshima","year":"2007","unstructured":"Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC (2007) Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 7(8):585\u2013598. \n                    https:\/\/doi.org\/10.1038\/nrc2189","journal-title":"Nat Rev Cancer"},{"key":"3555_CR26","doi-asserted-by":"publisher","unstructured":"Terpos E, Christoulas D, Gavriatopoulou M, Dimopoulos MA (2017) Mechanisms of bone destruction in multiple myeloma. Eur J Cancer Care (Engl) 26. doi:\n                    https:\/\/doi.org\/10.1111\/ecc.12761","DOI":"10.1111\/ecc.12761"},{"issue":"13","key":"3555_CR27","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1182\/blood.V98.13.3527","volume":"98","author":"N Giuliani","year":"2001","unstructured":"Giuliani N, Bataille R, Mancini C, Lazzaretti M, Barille S (2001) Myeloma cells induce imbalance in the osteoprotegerin\/osteoprotegerin ligand system in the human bone marrow environment. Blood 98(13):3527\u20133533","journal-title":"Blood"},{"issue":"26","key":"3555_CR28","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa030847","volume":"349","author":"E Tian","year":"2003","unstructured":"Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD Jr (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349(26):2483\u20132494. \n                    https:\/\/doi.org\/10.1056\/NEJMoa030847","journal-title":"N Engl J Med"},{"issue":"11","key":"3555_CR29","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1073\/pnas.0911929107","volume":"107","author":"S Vallet","year":"2010","unstructured":"Vallet S, Mukherjee S, Vaghela N, Hideshima T, Fulciniti M, Pozzi S, Santo L, Cirstea D, Patel K, Sohani AR, Guimaraes A, Xie W, Chauhan D, Schoonmaker JA, Attar E, Churchill M, Weller E, Munshi N, Seehra JS, Weissleder R, Anderson KC, Scadden DT, Raje N (2010) Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease. Proc Natl Acad Sci U S A 107(11):5124\u20135129. \n                    https:\/\/doi.org\/10.1073\/pnas.0911929107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3555_CR30","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/leu.2013.385","volume":"28","author":"R Silbermann","year":"2014","unstructured":"Silbermann R, Bolzoni M, Storti P, Guasco D, Bonomini S, Zhou D, Wu J, Anderson JL, Windle JJ, Aversa F, Roodman GD, Giuliani N (2014) Bone marrow monocyte-\/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma. Leukemia 28(4):951\u2013954. \n                    https:\/\/doi.org\/10.1038\/leu.2013.385","journal-title":"Leukemia"},{"issue":"4","key":"3555_CR31","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1182\/blood-2005-03-1080","volume":"106","author":"LA Ehrlich","year":"2005","unstructured":"Ehrlich LA, Chung HY, Ghobrial I, Choi SJ, Morandi F, Colla S, Rizzoli V, Roodman GD, Giuliani N (2005) IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma. Blood 106(4):1407\u20131414. \n                    https:\/\/doi.org\/10.1182\/blood-2005-03-1080","journal-title":"Blood"},{"issue":"6","key":"3555_CR32","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1182\/blood-2003-06-1992","volume":"103","author":"JW Lee","year":"2004","unstructured":"Lee JW, Chung HY, Ehrlich LA, Jelinek DF, Callander NS, Roodman GD, Choi SJ (2004) IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells. Blood 103(6):2308\u20132315. \n                    https:\/\/doi.org\/10.1182\/blood-2003-06-1992","journal-title":"Blood"},{"issue":"2","key":"3555_CR33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V96.2.671.014k24_671_675","volume":"96","author":"SJ Choi","year":"2000","unstructured":"Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD, Alsina M (2000) Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood 96(2):671\u2013675","journal-title":"Blood"},{"issue":"1","key":"3555_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1365-2141.2003.04040.x","volume":"120","author":"S Uneda","year":"2003","unstructured":"Uneda S, Hata H, Matsuno F, Harada N, Mitsuya Y, Kawano F, Mitsuya H (2003) Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM. Br J Haematol 120(1):53\u201355","journal-title":"Br J Haematol"},{"issue":"1","key":"3555_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1365-2141.2004.04864.x","volume":"125","author":"T Hashimoto","year":"2004","unstructured":"Hashimoto T, Abe M, Oshima T, Shibata H, Ozaki S, Inoue D, Matsumoto T (2004) Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1alpha and MIP-1beta correlates with lytic bone lesions in patients with multiple myeloma. Br J Haematol 125(1):38\u201341","journal-title":"Br J Haematol"},{"issue":"18","key":"3555_CR36","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1182\/blood-2010-05-283895","volume":"116","author":"K Noonan","year":"2010","unstructured":"Noonan K, Marchionni L, Anderson J, Pardoll D, Roodman GD, Borrello I (2010) A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma. Blood 116(18):3554\u20133563. \n                    https:\/\/doi.org\/10.1182\/blood-2010-05-283895","journal-title":"Blood"},{"issue":"16","key":"3555_CR37","doi-asserted-by":"publisher","first-page":"6840","DOI":"10.1158\/0008-5472.CAN-08-0402","volume":"68","author":"N Giuliani","year":"2008","unstructured":"Giuliani N, Lisignoli G, Colla S, Lazzaretti M, Storti P, Mancini C, Bonomini S, Manferdini C, Codeluppi K, Facchini A, Rizzoli V (2008) CC-chemokine ligand 20\/macrophage inflammatory protein-3alpha and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions. Cancer Res 68(16):6840\u20136850. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0402","journal-title":"Cancer Res"},{"issue":"2","key":"3555_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/leu.2015.259","volume":"30","author":"BD Palma","year":"2016","unstructured":"Palma BD, Guasco D, Pedrazzoni M, Bolzoni M, Accardi F, Costa F, Sammarelli G, Craviotto L, De Filippo M, Ruffini L, Omede P, Ria R, Aversa F, Giuliani N (2016) Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: role of chemokine (C-C motif) ligand 20. Leukemia 30(2):409\u2013416. \n                    https:\/\/doi.org\/10.1038\/leu.2015.259","journal-title":"Leukemia"},{"issue":"5","key":"3555_CR39","first-page":"469","volume":"5","author":"C Sachpekidis","year":"2015","unstructured":"Sachpekidis C, Hillengass J, Goldschmidt H, Mosebach J, Pan L, Schlemmer HP, Haberkorn U, Dimitrakopoulou-Strauss A (2015) Comparison of (18)F-FDG PET\/CT and PET\/MRI in patients with multiple myeloma. Am J Nucl Med Mol Imaging 5(5):469\u2013478","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"6","key":"3555_CR40","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/leu.2015.338","volume":"30","author":"C Pawlyn","year":"2016","unstructured":"Pawlyn C, Fowkes L, Otero S, Jones JR, Boyd KD, Davies FE, Morgan GJ, Collins DJ, Sharma B, Riddell A, Kaiser MF, Messiou C (2016) Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma? Leukemia 30(6):1446\u20131448. \n                    https:\/\/doi.org\/10.1038\/leu.2015.338","journal-title":"Leukemia"},{"issue":"1","key":"3555_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/blood-2017-03-774422","volume":"130","author":"L Rasche","year":"2017","unstructured":"Rasche L, Angtuaco E, McDonald JE, Buros A, Stein C, Pawlyn C, Thanendrarajan S, Schinke C, Samant R, Yaccoby S, Walker BA, Epstein J, Zangari M, van Rhee F, Meissner T, Goldschmidt H, Hemminki K, Houlston R, Barlogie B, Davies FE, Morgan GJ, Weinhold N (2017) Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma. Blood 130(1):30\u201334. \n                    https:\/\/doi.org\/10.1182\/blood-2017-03-774422","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3555-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3555-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3555-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:11:08Z","timestamp":1576023068000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3555-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3555"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3555-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]},"assertion":[{"value":"17 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for retrospective evaluation and publication was obtained from our institutional research ethics board. This study followed the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}